Related Experiment Videos
Non-pharmacological lowering of low-density lipoprotein by apheresis and surgical techniques
R S Lees1, L Cashin-Hemphill, A M Lees
1Harvard-MIT Division of Health Sciences and Technology, Cambridge, Massachusetts, USA. rsl@mit.edu
Insights
New data confirm long-term benefits of low-density lipoprotein (LDL) apheresis for patients with severe hypercholesterolemia resistant to drugs. This effective treatment with few side effects now surpasses surgical options for managing high cholesterol.
Area of Science:
- Cardiology
- Metabolic Disorders
- Pharmacology
Background:
- Severe hypercholesterolemia poses significant cardiovascular risks.
- Lipid-lowering drug therapy is not effective for all patients.
- Surgical interventions have historically been considered for refractory cases.
Purpose of the Study:
- To review recent data on the long-term benefits of LDL apheresis.
- To evaluate LDL apheresis as a treatment for severe, drug-refractory hypercholesterolemia.
- To compare apheresis with surgical alternatives.
Main Methods:
- Review of recent clinical data and studies.
- Analysis of treatment efficacy and side-effect profiles.
- Comparison of LDL apheresis with liver transplantation and ileal bypass.
Main Results:
- New data demonstrate clear clinical benefits from LDL apheresis.
- LDL apheresis significantly reduces low-density lipoprotein levels.
- The procedure has a low incidence of side effects.
Conclusions:
- LDL apheresis is a highly effective treatment for severe hypercholesterolemia unresponsive to drugs.
- Apheresis offers clear clinical advantages over surgical options.
- The efficacy and safety profile make apheresis the preferred method.
Abstract:
In the past year, new data have appeared on the long-term benefits of low-density lipoprotein apheresis in severely hypercholesterolemic patients who are refractory to lipid-lowering drug therapy. Such data are critical for clinical decision-making, because they confirm the hypothesis that the dramatic reduction in low-density lipoprotein made possible by this technique produces clear-cut clinical benefits. Because of its efficacy and low incidence of side-effects, apheresis for severe drug-refractory hypercholesterolemia has superseded surgical approaches, such as liver transplantation or ileal bypass.